Nuvation Bio NUVB Less than 12 months
Less than 12 months at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's less than 12 months.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's less than 12 months?
- Nuvation Bio (NUVB) reported less than 12 months of $18.16M in Q4 2025.
- How has Nuvation Bio's less than 12 months changed year-over-year?
- Nuvation Bio's less than 12 months decreased by 86.2% year-over-year, from $131.92M to $18.16M.
- What is the long-term trend for Nuvation Bio's less than 12 months?
- Over 4 years (2021 to 2025), Nuvation Bio's less than 12 months has grown at a -56.8% compound annual growth rate (CAGR), from $523.28M to $18.16M.